Saturday, August 9, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Dynamin 1-Driven Recycling of Glycosylated N-Cadherin Supports Mesenchymal Plasticity to Fuel Ovarian Cancer Metastasis

August 8, 2025
in Cancer
Reading Time: 4 mins read
0
blank
65
SHARES
595
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Ovarian cancer remains one of the deadliest gynecological malignancies worldwide, with an alarmingly low five-year survival rate for patients diagnosed at advanced stages. Central to its fatal progression is the peritoneal metastasis, a complex biological phenomenon that enables cancer cells to disseminate within the abdominal cavity. Despite extensive research, therapeutic interventions have seen limited success, largely due to the elusive nature of the underlying molecular drivers orchestrating metastatic dissemination. Recent scientific endeavors have shifted focus to the epithelial-mesenchymal transition (EMT), a dynamic cellular program that endows epithelial cells with mesenchymal properties, enhancing their motility and invasiveness. Yet, direct pharmacological targeting of EMT remains an unsolved challenge because traditional transcriptional regulators involved in this transition often play vital roles in normal tissue maintenance, and exhibit redundancy.

Emerging from this landscape, a groundbreaking study has brought to light a novel non-transcriptional regulator intricately involved in sustaining the plastic mesenchymal state characteristic of metastatic ovarian cancer cells. At the heart of this discovery is Dynamin 1 (DNM1), a GTPase classically known for its pivotal role in endocytosis. Using integrative bioinformatics analyses across The Cancer Genome Atlas (TCGA) datasets, encompassing a broad spectrum of over 8,000 patient samples from 20 cancer types, researchers employed advanced computational frameworks including master regulator algorithms and the Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNE). This comprehensive approach unveiled markedly elevated expression of DNM1 in ovarian cancer patients exhibiting advanced clinical stages and mesenchymal subtypes, with a compelling correlation to diminished progression-free and post-relapse survival, positioning DNM1 as a putative driver of tumor aggressiveness.

Functionally dissecting DNM1’s contribution, in vitro experiments delineated its crucial role in regulating EMT phenotypes. Silencing DNM1 expression in highly metastatic ovarian cancer cell lines resulted in a significant attenuation of mesenchymal traits—cells exhibited reduced migratory capacity and decreased expression of N-cadherin, a key adhesion molecule intimately linked to EMT and metastatic competence. Conversely, ectopic overexpression of DNM1 in otherwise non-metastatic ovarian cancer cells induced a pronounced acquisition of invasive characteristics, concomitant with upregulated N-cadherin. These functional modulations underscore the indispensable role of DNM1 in tuning the dynamic equilibrium between epithelial and mesenchymal states.

ADVERTISEMENT

Validating these findings in vivo, murine models of peritoneal metastasis reinforced the functional indispensability of DNM1 in metastatic colonization. Mice bearing ovarian tumors with targeted DNM1 knockdown manifested a stark reduction in tumor dissemination across the peritoneum, corroborating the in vitro insights and implicating DNM1 as a formidable mediator of metastatic colonization. Delving deeper into mechanistic pathways, the research revealed that DNM1 orchestrates EMT progression by regulating the endocytic recycling of glycosylated N-cadherin. This post-translational trafficking mechanism sustains the plasticity and polarity of mesenchymal cancer cells, facilitating enhanced migratory and invasive capacities essential for metastasis.

Complementing these mechanistic insights, integrated epigenomic and transcriptomic analyses, harnessing ATAC-seq and RNA-seq technologies, unveiled a potential suppressive axis in non-metastatic ovarian cancer cells. The enzyme beta-1,3-galactosyltransferase 1 (B3GALT1) emerged as upregulated in such contexts, hypothesized to antagonize EMT by impeding the recycling of N-cadherin, thereby dampening mesenchymal plasticity. This finding not only delineates differential regulatory landscapes underpinning metastatic versus non-metastatic states but also suggests a complex interplay between glycosylation enzymes and endocytic trafficking in cancer progression.

Beyond molecular intricacies, the study illuminated surprising therapeutic implications relating to nanoparticle-mediated drug delivery. Metastatic ovarian cancer cells characterized by heightened DNM1 activity displayed increased sensitivity to nanoparticle uptake, attributed to their augmented endocytic machinery. This phenomenon hints at the tantalizing prospect of exploiting DNM1-mediated endocytosis to enhance the efficacy of nanodrugs, potentially ushering in a paradigm shift in targeted ovarian cancer therapies that transcends conventional approaches.

Taken together, these findings establish a previously unrecognized DNM1-N-cadherin axis as a fundamental regulator of EMT plasticity and metastatic virulence in ovarian cancer. By linking endocytic trafficking mechanisms to cellular phenotype regulation, the research bridges pivotal gaps in our understanding of metastatic biology. The identification of DNM1 as both a biomarker and mechanistic driver opens promising therapeutic avenues, including targeted nanodrug delivery strategies that capitalize on inherent cellular vulnerabilities.

This paradigm-shifting work, titled “Dynamin 1-mediated endocytic recycling of glycosylated N-cadherin sustains the plastic mesenchymal state to promote ovarian cancer metastasis”, was published on April 9, 2025 in the journal Protein & Cell. It exemplifies how integrating multi-omic datasets with experimental rigor can unravel complex cancer biology, moving beyond traditional transcription factor-centric models toward novel non-transcriptional pathways with translational relevance.

Beyond expanding our molecular grasp of ovarian cancer metastasis, these insights may transcend this malignancy, as DNM1 and endocytic pathways are likely implicated in diverse tumor contexts exhibiting EMT-driven dissemination. Future research should prioritize the development of specific inhibitors targeting DNM1-mediated endocytic recycling and refine nanotherapeutic carriers tailored to exploit this pathway. Such innovations promise to significantly advance precision oncology, offering hope to patients grappling with aggressive and metastatic ovarian cancer.

Ultimately, this pioneering study underscores the transformative potential of targeting non-transcriptional regulators of EMT, particularly those involved in membrane trafficking and protein recycling, a frontier that until now has remained largely unexplored. By charting this novel territory, the research champions a new era of metastasis-targeted therapies with the potential to improve clinical outcomes for one of the most challenging cancers faced by modern medicine.


Article Title: Dynamin 1-mediated endocytic recycling of glycosylated N-cadherin sustains the plastic mesenchymal state to promote ovarian cancer metastasis
News Publication Date: 9-Apr-2025
Web References: https://doi.org/10.1093/procel/pwaf019
Image Credits: Yuee Cai, Zhangyan Guan, Yin Tong, Weiyang Zhao, Jiangwen Zhang, Ling Peng, Philip P. C. Ip, Sally K. Y. To, Alice S. T. Wong
Keywords: Ovarian cancer, Epithelial-mesenchymal transition, Dynamin 1, Endocytic recycling, N-cadherin, Metastasis, Glycosylation, Nanoparticle uptake, Biomarker, Targeted therapy

Tags: bioinformatics in cancer researchdynamin 1 role in ovarian cancerendocytosis in cancer cellsepithelial-mesenchymal transition challengesglycosylated N-cadherin recyclingmesenchymal plasticity in cancermolecular drivers of cancer disseminationnon-transcriptional regulators in cancerovarian cancer metastasis mechanismspatient survival rates in ovarian cancerperitoneal metastasis in ovarian cancertherapeutic targets for ovarian cancer
Share26Tweet16
Previous Post

Parental Workplace Chemical Exposure Linked to Autism Risk in Offspring

Next Post

A Breakthrough Solution for Heart Health

Related Posts

blank
Cancer

Revolutionizing Fetal Congenital Heart Disease: MRI’s Impact

August 9, 2025
blank
Cancer

Enhancing Pediatric Abdominal MRI Quality with Deep Learning

August 9, 2025
blank
Cancer

FAM111B Knockdown Suppresses Ovarian Cancer by Downregulating MYC

August 9, 2025
blank
Cancer

Lung Ultrasound Transforms Neonatal and Pediatric Respiratory Care

August 9, 2025
blank
Cancer

Understanding Tenosynovial Giant Cell Tumors in Kids

August 9, 2025
blank
Cancer

120 mmHg Limit: Key to Safe Intussusception Reduction

August 8, 2025
Next Post
blank

A Breakthrough Solution for Heart Health

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27531 shares
    Share 11009 Tweet 6881
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    943 shares
    Share 377 Tweet 236
  • Bee body mass, pathogens and local climate influence heat tolerance

    641 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    507 shares
    Share 203 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Revolutionizing Fetal Congenital Heart Disease: MRI’s Impact
  • Distinct Coral Reef Regions Identified in Red Sea
  • Scientists Discover Novel Mechanism Behind Cellular Tolerance to Anticancer Drugs
  • Enhancing Pediatric Abdominal MRI Quality with Deep Learning

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,860 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading